总共 208 条专利。查看更多...

	公开号	公开日	申请号	申请日

	1. CN102766112B	2014/3/19	CN20121282333	2012/8/10
	专利标题：A kind of repaglinide synthetic method 专利权人：Hebei Fuge Pharmacy Co., Ltd.;

	2. US20140066482A1	2014/3/6	US14/079127	2013/11/13
	专利标题：Pharmaceutical formulation comprising metformin and repaglinide 专利权人：Novo Nordisk A/s; The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.

	3. CN103610677A	2014/3/5	CN20131565684	2013/11/14
	专利标题：A kind of repaglinide tablet and preparation method thereof 专利权人：

	4. CN103599540A	2014/2/26	CN20131571284	2013/11/15
	专利标题：The medical composition and its use that contains glinides and vitamin b group 专利权人：

	5. CN103565768A	2014/2/12	CN20131418028	2013/9/11
	专利标题：Repaglinide slow releasing preparation and preparation method thereof 专利权人：

	6. CN103505431A	2014/1/15	CN20121218265	2012/6/27
	专利标题：A kind of repaglinide 专利权人：

	7. CN103494816A	2014/1/8	CN20131468638	2013/9/29
	专利标题：A kind of pharmaceutical composition for the treatment of diabetes 专利权人：

	8. CN103497178A	2014/1/8	CN20131446196	2013/9/27
	专利标题：The irbesartan repaglinide is amorphous article altogether 专利权人：

	9. EP2026787B1	2013/12/25	EP20070728962	2007/5/10
	专利标题：Tablet formulation comprising repaglinide and metformin 专利权人：Novo Nordisk A/s; The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.

	10. CN103432092A	2013/12/11	CN20131340837	2013/8/7
	专利标题：Sustained release preparation of repaglinide 专利权人：